<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS Genet</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosgen</journal-id><journal-title-group><journal-title>PLoS Genetics</journal-title></journal-title-group><issn pub-type="ppub">1553-7390</issn><issn pub-type="epub">1553-7404</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">19629171</article-id><article-id pub-id-type="publisher-id">09-PLGE-RA-0651R2</article-id><article-id pub-id-type="doi">10.1371/journal.pgen.1000579</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Genetics and Genomics</subject><subject>Genetics and Genomics/Animal Genetics</subject><subject>Genetics and Genomics/Disease Models</subject><subject>Genetics and Genomics/Genetics of Disease</subject><subject>Genetics and Genomics/Medical Genetics</subject></subj-group></article-categories><title-group><article-title>A Missense Mutation in the <italic>SERPINH1</italic> Gene in Dachshunds with Osteogenesis Imperfecta</article-title><alt-title alt-title-type="running-head"><italic>SERPINH1</italic> Mutation in Dogs</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Dr&#x000f6;gem&#x000fc;ller</surname><given-names>Cord</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Becker</surname><given-names>Doreen</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Brunner</surname><given-names>Adrian</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Haase</surname><given-names>Bianca</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kircher</surname><given-names>Patrick</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Seeliger</surname><given-names>Frank</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Fehr</surname><given-names>Michael</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Baumann</surname><given-names>Ulrich</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Lindblad-Toh</surname><given-names>Kerstin</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref><xref ref-type="aff" rid="aff7"><sup>7</sup></xref></contrib><contrib contrib-type="author"><name><surname>Leeb</surname><given-names>Tosso</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>&#x0002a;</sup></xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Institute of Genetics, Vetsuisse Faculty, University of Berne, Berne, Switzerland</addr-line></aff><aff id="aff2"><label>2</label><addr-line>Department of Clinical Veterinary Medicine, Vetsuisse Faculty, University of Berne, Berne, Switzerland</addr-line></aff><aff id="aff3"><label>3</label><addr-line>Astra Zeneca Safety Assessment, R&#x00026;D S&#x000f6;dert&#x000e4;lje, S&#x000f6;dert&#x000e4;lje, Sweden</addr-line></aff><aff id="aff4"><label>4</label><addr-line>Clinic for Small Animals, University of Veterinary Medicine Hannover, Hannover, Germany</addr-line></aff><aff id="aff5"><label>5</label><addr-line>Department of Chemistry and Biochemistry, University of Berne, Berne, Switzerland</addr-line></aff><aff id="aff6"><label>6</label><addr-line>Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America</addr-line></aff><aff id="aff7"><label>7</label><addr-line>Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Barsh</surname><given-names>Gregory S.</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">Stanford University School of Medicine, United States of America</aff><author-notes><corresp id="cor1">&#x0002a; E-mail: <email>Tosso.Leeb@itz.unibe.ch</email></corresp><fn fn-type="con"><p>Conceived and designed the experiments: CD TL. Performed the experiments: CD DB AB BH PK MF UB. Analyzed the data: CD UB TL. Contributed reagents/materials/analysis tools: FS KLT. Wrote the paper: CD TL.</p></fn></author-notes><pub-date pub-type="collection"><month>7</month><year>2009</year></pub-date><!-- Fake ppub added to accomodate plos workflow change from 03/2008 and 03/2009 --><pub-date pub-type="ppub"><month>7</month><year>2009</year></pub-date><pub-date pub-type="epub"><day>24</day><month>7</month><year>2009</year></pub-date><volume>5</volume><issue>7</issue><elocation-id>e1000579</elocation-id><history><date date-type="received"><day>17</day><month>4</month><year>2009</year></date><date date-type="accepted"><day>25</day><month>6</month><year>2009</year></date></history><permissions><copyright-statement>Dr&#x000f6;gem&#x000fc;ller et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</copyright-statement></permissions><abstract><p>Osteogenesis imperfecta (OI) is a hereditary disease occurring in humans and dogs. It is characterized by extremely fragile bones and teeth. Most human and some canine OI cases are caused by mutations in the <italic>COL1A1</italic> and <italic>COL1A2</italic> genes encoding the subunits of collagen I. Recently, mutations in the <italic>CRTAP</italic> and <italic>LEPRE1</italic> genes were found to cause some rare forms of human OI. Many OI cases exist where the causative mutation has not yet been found. We investigated Dachshunds with an autosomal recessive form of OI. Genotyping only five affected dogs on the 50 k canine SNP chip allowed us to localize the causative mutation to a 5.82 Mb interval on chromosome 21 by homozygosity mapping. Haplotype analysis of five additional carriers narrowed the interval further down to 4.74 Mb. The <italic>SERPINH1</italic> gene is located within this interval and encodes an essential chaperone involved in the correct folding of the collagen triple helix. Therefore, we considered <italic>SERPINH1</italic> a positional and functional candidate gene and performed mutation analysis in affected and control Dachshunds. A missense mutation (c.977C&#x0003e;T, p.L326P) located in an evolutionary conserved domain was perfectly associated with the OI phenotype. We thus have identified a candidate causative mutation for OI in Dachshunds and identified a fifth OI gene.</p></abstract><abstract abstract-type="summary"><title>Author Summary</title><p>Osteogenesis imperfecta (OI) is a genetic condition of humans and dogs characterized by extremely fragile bones and teeth. Most human OI cases are caused by defects in one of two collagen genes. Mutations in two other genes related to collagen maturation can also lead to OI in some patients. We studied Dachshunds with OI and initially investigated the two known collagen genes that are normally mutated in OI but did not find a mutation. Subsequently, we performed a search for shared segments across the entire genome in five affected Dachshunds. This experiment revealed that the causative mutation for OI in Dachshunds is located on dog chromosome 21. The <italic>SERPINH1</italic> gene known to be involved in collagen maturation is located in this shared genome region. We sequenced the <italic>SERPINH1</italic> gene in healthy and affected Dachshunds and found a single mutation exclusively shared by all affected dogs but not by healthy controls. Thus we have identified <italic>SERPINH1</italic> as a fifth OI gene and a mutation within this gene as the most likely cause of OI in Dachshunds. The knowledge of this mutation enables genetic testing and will allow breeders to eradicate the deleterious allele from the Dachshund breeding population. <italic>SERPINH1</italic> mutations might also be responsible for some human OI forms, where the causative mutation has not yet been identified.</p></abstract><counts><page-count count="9"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Collagen I is the most abundant protein in the human body and its highly ordered fibril structure is responsible for its special mechanical properties. Together with inorganic hydroxylapatite it is the main component of bones and gives them elasticity while the hydroxylapatite alone would be very brittle. Defects in the structure of the highly ordered collagen I triple helix lead to osteogenesis imperfecta (OI), a disease characterized by extremely fragile bones and teeth. OI is sometimes also accompanied by blue sclera, hearing loss, dwarfism, dentinogenesis imperfecta, and other complications. Seven subtypes of human OI are distinguished based on the underlying genetic defects and phenotypic severity <xref ref-type="bibr" rid="pgen.1000579-Rau1">&#x0005b;1&#x0005d;</xref>. OI affects an estimated 6 to 7 per 100,000 people worldwide &#x0005b;<ext-link ext-link-type="uri" xlink:href="http://ghr.nlm.nih.gov/condition=osteogenesisimperfecta/">http://ghr.nlm.nih.gov/condition=osteogenesisimperfecta/</ext-link>&#x0005d;. Approximately 85&#x02013;90&#x00025; of the human OI cases are caused by mutations in the <italic>COL1A1</italic> or <italic>COL1A2</italic> genes encoding the two different subunits of collagen I. More than 800 distinct mutations in these two genes have been described and most of them lead to autosomal dominant forms of OI <xref ref-type="bibr" rid="pgen.1000579-Marini1">&#x0005b;2&#x0005d;</xref>. The maturation and correct folding of collagens is a complicated process, which involves a large number of accessory proteins and chaperones. Recently mutations in two of these accessory proteins were found in patients with autosomal recessive forms of OI <xref ref-type="bibr" rid="pgen.1000579-Cabral1">&#x0005b;3&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pgen.1000579-Bodian1">&#x0005b;7&#x0005d;</xref>. Both of these proteins are involved in the 3-hydroxylation of a specific proline residue in collagen I. One represents the enzymatically active prolyl-3-hydroxylase 1 itself and is encoded by the <italic>LEPRE1</italic> gene <xref ref-type="bibr" rid="pgen.1000579-Cabral1">&#x0005b;3&#x0005d;</xref>. The other is called cartilage-associated protein (CRTAP) and forms a complex with the prolyl-3-hydroxylase <xref ref-type="bibr" rid="pgen.1000579-Morello1">&#x0005b;4&#x0005d;</xref>. For some human OI cases the underlying mutation has not yet been found.</p><p>OI also occurs in dogs and the dog may represent a better model for human OI than genetically engineered mice because of its larger body size and the resulting similarity of mechanical forces that act on the skeleton. OI in dogs has been described in Golden Retrievers, Beagles, Collies, Poodles, Norwegian Elkhounds, and Bedlington Terriers <xref ref-type="bibr" rid="pgen.1000579-Campbell1">&#x0005b;8&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pgen.1000579-Schmidt1">&#x0005b;12&#x0005d;</xref>. In Golden Retrievers a <italic>COL1A1</italic> mutation and in Beagles a <italic>COL1A2</italic> mutation has been reported to cause OI <xref ref-type="bibr" rid="pgen.1000579-Campbell1">&#x0005b;8&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000579-Campbell2">&#x0005b;9&#x0005d;</xref>. For other canine OI cases the underlying genetic defect has not been elucidated. We have observed a severe form of OI in rough-coated Dachshunds that is inherited as a monogenic autosomal recessive trait <xref ref-type="bibr" rid="pgen.1000579-Seeliger1">&#x0005b;13&#x0005d;</xref>. In our initial analysis of the OI Dachshunds we did not find any mutations in the <italic>COL1A1</italic> or <italic>COL1A2</italic> genes. Therefore, we hypothesized that a mutation in a novel OI gene may be responsible for the observed bone defects in Dachshunds. Consequently, we started a positional cloning approach to identify this mutation.</p></sec><sec id="s2"><title>Results</title><sec id="s2a"><title>Collection of informative families and exclusion of <italic>COL1A1</italic> and <italic>COL1A2</italic></title><p>We collected samples from six Dachshund families segregating for congenital OI (<xref ref-type="fig" rid="pgen-1000579-g001">Figure 1</xref>; <xref ref-type="supplementary-material" rid="pgen.1000579.s007">Video S1</xref>). The parents of all available cases were healthy (<xref ref-type="supplementary-material" rid="pgen.1000579.s001">Figure S1</xref>). The pedigrees were consistent with a monogenic autosomal recessive inheritance although the ratio of affected Dachshunds from the presumed carrier x carrier matings was slightly higher than expected with 14 out of 36 total pups affected instead of the expected 9/36. The available pedigree records indicate that the affected dogs from the German Dachshund breeding population share common ancestors and most likely trace back to a single common founder. As the OI phenotype in Dachshunds shows striking clinical similarities to human OI forms, we initially hypothesized that mutations in <italic>COL1A1</italic> or <italic>COL1A2</italic> might cause the canine disease. In order to validate whether a mutation in one of these genes might be responsible for OI, we genotyped three gene associated microsatellite markers derived from the surrounding genome sequence of <italic>COL1A1</italic> (located on chromosome 9 (CFA 9) at 29.5 Mb) and <italic>COL1A2</italic> (located on CFA 14 at 22.8 Mb), respectively. Two-point linkage analysis in the six available families clearly excluded the <italic>COL1A2</italic> gene but indicated a suggestive linkage of OI to the region of <italic>COL1A1</italic> with a positive LOD score of 1.5 (<xref ref-type="supplementary-material" rid="pgen.1000579.s002">Table S1</xref>). However, the re-sequencing of <italic>COL1A1</italic> using DNA of four affected and four healthy Dachshunds did not reveal any disease associated sequence polymorphism within the 51 coding exons and flanking intron regions of the <italic>COL1A1</italic> gene. Furthermore, haplotype analysis revealed five different CFA 9 microsatellite marker haplotypes in affected dogs, which was not compatible with our assumption of a single founder mutation in all OI affected dogs.</p><fig id="pgen-1000579-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1000579.g001</object-id><label>Figure 1</label><caption><title>Radiographs of an OI affected and a control Dachshund demonstrating generalized osteopenia in canine OI.</title><p>(A) Foreleg of an affected Dachshund. Note the overall decreased radiopacity of the skeleton with the thin compact bone and inhomogeneous, shallow trabeculation in the entire foreleg. No pathologic fractures were seen in this puppy. (B) Foreleg of a control Dachshund. (C) Skull of an affected puppy. There is decreased opacity and poor delineation of the skull. Note the lack of visualization of the lamina dura of the dental alveoli leading to a &#x0201c;floating&#x0201d; appearance of the teeth, which themselves show a lack of mineralization. (D) Skull of a control dog.</p></caption><graphic xlink:href="pgen.1000579.g001"/></fig></sec><sec id="s2b"><title>Mapping of the causative mutation</title><p>Based on the pedigrees of our samples we hypothesized that the affected Dachshunds most likely were inbred to one single founder animal. Under this scenario the affected Dachshunds were expected to be identical by descent (IBD) for the causative mutation and flanking chromosomal segments. Therefore, we decided to apply a homozygosity mapping approach to determine the position of the mutation in the canine genome. We genotyped approximately 50,000 evenly spaced SNPs from five affected dogs and five obligate carriers. We analyzed the cases for extended regions of homozygosity with simultaneous allele sharing. Only one genome region fulfilled our search criteria (<xref ref-type="supplementary-material" rid="pgen.1000579.s003">Table S2</xref>). On CFA 21 all five affected genotyped dogs were homozygous and shared identical alleles over 102 SNP markers corresponding to a 5.82 Mb interval from 23.58&#x02013;29.40 Mb (<xref ref-type="fig" rid="pgen-1000579-g002">Figure 2</xref>). We then examined the five obligate carriers for the mutation and reconstructed one copy of the disease-associated haplotype in each dog. One of the carriers showed a recombination event, which allowed us to narrow down the critical interval harboring the causative mutation to 4.74 Mb from 24.66&#x02013;29.40 Mb (<xref ref-type="fig" rid="pgen-1000579-g002">Figure 2</xref>).</p><fig id="pgen-1000579-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1000579.g002</object-id><label>Figure 2</label><caption><title>Mapping of the OI mutation.</title><p>SNP genotypes of selected CFA 21 markers are shown. Alternate SNP alleles are represented in blue and yellow. The two copies of CFA 21 for each dog are separated by a vertical dashed line. The analysis of SNP genotypes from five affected dogs indicated that they had extended homozygous regions on CFA 21 (indicated as blue blocks). The boundaries of these homozygous blocks are given in Mb. All five affected dogs had homozygous intervals with shared alleles between 23.58 Mb and 29.40 Mb. We also genotyped five parents of affected dogs assumed to be carriers of the mutation. One of these carriers, animal no. 33, had one copy of the disease-associated haplotype in the critical interval (indicated in blue). In comparison to the affected dogs it was homozygous for the opposite SNP alleles (indicated in yellow) at several positions proximal of 24.66 Mb and distal of 29.40 Mb. Thus &#x02013; assuming that it resides on the common blue haplotype block &#x02013; the causative mutation is located within the interval from 24.66 Mb to 29.40 Mb on CFA 21.</p></caption><graphic xlink:href="pgen.1000579.g002"/></fig></sec><sec id="s2c"><title>Identification of a functional candidate gene and mutation analysis</title><p>As the quality of dog genome annotation is still far from perfect, we inferred the gene annotation of the mapped interval from the corresponding human interval. The dog OI interval corresponds to two human segments from 3.59&#x02013;3.84 Mb and from 71.30&#x02013;76.48 Mb on HSA 11. The two human intervals contain 98 annotated genes including 8 annotated pseudogenes (NCBI MapViewer, build 36.3). A careful inspection of these genes and database searches of their presumed function revealed <italic>SERPINH1</italic> as a functional candidate gene within the critical interval at 26.0 Mb on CFA 21. <italic>SERPINH1</italic> encodes a serine protease inhibitor, also called heat shock protein 47 (HSP47) or collagen binding protein 1. <italic>Serpinh1</italic> deficient mice die at around day 11 of development due to defective collagen synthesis <xref ref-type="bibr" rid="pgen.1000579-Nagai1">&#x0005b;14&#x0005d;</xref> and it was shown that <italic>Serpinh1<sup>&#x02212;/&#x02212;</sup></italic> fibroblasts produce abnormally thin and branched collagen type I fibres <xref ref-type="bibr" rid="pgen.1000579-Ishida1">&#x0005b;15&#x0005d;</xref>. In order to further validate <italic>SERPINH1</italic> as positional candidate gene for OI, we genotyped two gene associated microsatellite markers derived from the surrounding genome sequence of CFA 21 (<xref ref-type="supplementary-material" rid="pgen.1000579.s002">Table S1</xref>). The obtained LOD score of 4.1 conclusively confirmed the linkage of OI to the candidate gene region in the Dachshund families. All OI affected dogs showed homozygosity at both tested microsatellites and all genotyped parents had one copy of the disease associated haplotype. We therefore investigated whether mutations in the canine <italic>SERPINH1</italic> gene might be responsible for the OI phenotype. We designed PCR primers for the amplification of the four coding exons and determined the genomic sequence of two affected and two control dogs. This analysis revealed twelve polymorphisms including three non-synonymous substitutions (<xref ref-type="table" rid="pgen-1000579-t001">Table 1</xref>). Of these polymorphisms only a single SNP located in <italic>SERPINH1</italic> exon 5 (c.977T&#x0003e;C; <xref ref-type="fig" rid="pgen-1000579-g003">Figure 3</xref>) showed perfect association to the OI phenotype (<xref ref-type="table" rid="pgen-1000579-t002">Table 2</xref>, <xref ref-type="supplementary-material" rid="pgen.1000579.s001">Figure S1</xref>). All 11 affected dogs were homozygous C/C and all 13 known carriers were heterozygous C/T. One grandmother and 16 out of 22 healthy full- and half-sibs of OI affected dogs were also heterozygous C/T. None of 66 unrelated healthy Dachshunds had the homozygous C/C genotype, but twelve of them were also presumed carriers with the C/T genotype. Thus the allele frequency of the deleterious C-allele within the unrelated Dachshunds was 18&#x00025;. The mutation was encountered in wire-haired and short-haired Dachshunds. The mutant C-allele was absent from 79 control dogs from 75 diverse dog breeds (<xref ref-type="supplementary-material" rid="pgen.1000579.s003">Table S2</xref>). RT-PCR on bone cDNA confirmed that the <italic>SERPINH1</italic> RNA is normally spliced in an affected dog. We sequenced the cDNA from an affected dog and it did contain the mutant C-nucleotide at position &#x0002b;977 confirming that the mutant mRNA is expressed at normal levels. The c.977T&#x0003e;C substitution is predicted to result in an exchange of a highly conserved leucine to a proline in the SERPINH1 protein sequence (p.L326P, <xref ref-type="fig" rid="pgen-1000579-g004">Figure 4</xref>). We modeled the wildtype and mutant SERPINH1 protein structures based on experimentally determined structures of serpins and found that the p.L326P mutation indeed affects the three-dimensional structure of SERPINH1 (<xref ref-type="fig" rid="pgen-1000579-g005">Figure 5</xref>).</p><fig id="pgen-1000579-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1000579.g003</object-id><label>Figure 3</label><caption><title>Electropherograms of the <italic>SERPINH1</italic> c.977T&#x0003e;C mutation.</title><p>Representative sequence traces of PCR products amplified from genomic DNA of three dogs with the different genotypes are shown.</p></caption><graphic xlink:href="pgen.1000579.g003"/></fig><fig id="pgen-1000579-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1000579.g004</object-id><label>Figure 4</label><caption><title>Multispecies alignment of the SERPINH1 protein sequence.</title><p>The SERPINH1 protein sequence is highly conserved among all vertebrates. The p.L326P mutation in OI Dachshunds is indicated by an arrow. It affects a leucine residue, which is perfectly conserved from human to zebrafish across all investigated species. The sequences for the alignment were taken from the following accessions: XP_542305 (dog), NP_001226 (human), NP_001039528 (cattle), XP_001494735 (horse), NP_033955 (mouse), NP_058869 (rat), NP_990622 (chicken), NP_001080259 (Xenopus laevis), NP_571279 (zebrafish).</p></caption><graphic xlink:href="pgen.1000579.g004"/></fig><fig id="pgen-1000579-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1000579.g005</object-id><label>Figure 5</label><caption><title>Homology models of wildtype and mutant SERPINH1.</title><p>(A) Ribbon model of SERPINH1. Leu326 is located on the lower left with its side-chain drawn as ball-and-stick in cyan. The segment homologous to the reactive center loop of antiproteolytically active serpins is shown in red. Helices are colored magenta, sheets are depicted in green. (B) Close-up of the mutation site. Wildtype amino acids have carbon atoms colored in orange with the exception of Leu326 (cyan), while the mutant carbon atoms are drawn in green. Oxygens are shown in red and nitrogen atoms in blue. The H-bond between Leu326-NH and Leu321-O is indicated with a distance of 2.9 &#x000c5;. Some distortions are visible around the mutation site.</p></caption><graphic xlink:href="pgen.1000579.g005"/></fig><table-wrap id="pgen-1000579-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1000579.t001</object-id><label>Table 1</label><caption><title><italic>SERPINH1</italic> gene polymorphisms</title></caption><alternatives><graphic id="pgen-1000579-t001-1" xlink:href="pgen.1000579.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">Polymorphism (cDNA)<xref ref-type="table-fn" rid="nt101">a</xref></td><td align="left" rowspan="1" colspan="1">Position within <italic>SERPINH1</italic> gene</td><td align="left" rowspan="1" colspan="1">Protein</td><td align="left" rowspan="1" colspan="1">Association with OI<xref ref-type="table-fn" rid="nt102">b</xref></td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">c.-28C&#x0003e;T</td><td align="left" rowspan="1" colspan="1">exon 2, 5&#x02032;-UTR</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">Homozygous mutant genotype in OI and control dogs</td></tr><tr><td align="left" rowspan="1" colspan="1">c.47T&#x0003e;C</td><td align="left" rowspan="1" colspan="1">exon 2</td><td align="left" rowspan="1" colspan="1">p.V16A</td><td align="left" rowspan="1" colspan="1">Mutant allele only in control dogs</td></tr><tr><td align="left" rowspan="1" colspan="1">c.83C&#x0003e;T</td><td align="left" rowspan="1" colspan="1">exon 2</td><td align="left" rowspan="1" colspan="1">p.A28V</td><td align="left" rowspan="1" colspan="1">Homozygous mutant genotype in OI and control dogs</td></tr><tr><td align="left" rowspan="1" colspan="1">c.471G&#x0003e;A</td><td align="left" rowspan="1" colspan="1">exon 2</td><td align="left" rowspan="1" colspan="1">silent</td><td align="left" rowspan="1" colspan="1">Homozygous mutant genotype in OI and control dogs</td></tr><tr><td align="left" rowspan="1" colspan="1">c.621G&#x0003e;A</td><td align="left" rowspan="1" colspan="1">exon 2</td><td align="left" rowspan="1" colspan="1">silent</td><td align="left" rowspan="1" colspan="1">Mutant allele only in control dogs</td></tr><tr><td align="left" rowspan="1" colspan="1">c.622&#x0002b;8T&#x0003e;C</td><td align="left" rowspan="1" colspan="1">intron 2</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">Mutant allele only in control dogs</td></tr><tr><td align="left" rowspan="1" colspan="1">c.721&#x0002b;52G&#x0003e;A</td><td align="left" rowspan="1" colspan="1">intron 3</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">Mutant allele only in control dogs</td></tr><tr><td align="left" rowspan="1" colspan="1">c.885A&#x0003e;G</td><td align="left" rowspan="1" colspan="1">exon 4</td><td align="left" rowspan="1" colspan="1">silent</td><td align="left" rowspan="1" colspan="1">Mutant allele also in a healthy dog from another breed</td></tr><tr><td align="left" rowspan="1" colspan="1">c.954&#x0002b;28T&#x0003e;C</td><td align="left" rowspan="1" colspan="1">intron 4</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">Mutant allele only in control dogs</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>c.977T&#x0003e;C</bold></td><td align="left" rowspan="1" colspan="1"><bold>exon 5</bold></td><td align="left" rowspan="1" colspan="1"><bold>p.L326P</bold></td><td align="left" rowspan="1" colspan="1"><bold>Homozygous mutant genotypes exclusively in OI Dachshunds</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">c.1059C&#x0003e;T</td><td align="left" rowspan="1" colspan="1">exon 5</td><td align="left" rowspan="1" colspan="1">silent</td><td align="left" rowspan="1" colspan="1">Homozygous mutant genotype in OI and control dogs</td></tr><tr><td align="left" rowspan="1" colspan="1">c.1107C&#x0003e;T</td><td align="left" rowspan="1" colspan="1">exon 5</td><td align="left" rowspan="1" colspan="1">silent</td><td align="left" rowspan="1" colspan="1">Mutant allele only in control dogs</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt101"><label>a</label><p>Numbering refers to accession no. XM_542305 (this RefSeq model RNA is incorrectly annotated as <italic>SERPINH2</italic>, it does represent the putative canine <italic>SERPINH1</italic> mRNA sequence)</p></fn><fn id="nt102"><label>b</label><p>The canine genome reference sequence was considered to represent the wildtype state. Sequence variants with respect to this sequence are designated &#x0201c;mutant&#x0201d; alleles or genotypes.</p></fn></table-wrap-foot></table-wrap><table-wrap id="pgen-1000579-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1000579.t002</object-id><label>Table 2</label><caption><title><italic>SERPINH1</italic> genotype frequencies</title></caption><alternatives><graphic id="pgen-1000579-t002-2" xlink:href="pgen.1000579.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td colspan="4" align="center" rowspan="1">Dachshunds</td><td align="left" rowspan="1" colspan="1">Other breeds</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>SERPINH1</italic></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">OI affected (n&#x0200a;&#x0003d;&#x0200a;11)</td><td align="left" rowspan="1" colspan="1">OI carrier (n&#x0200a;&#x0003d;&#x0200a;13)</td><td align="left" rowspan="1" colspan="1">Control, related (n&#x0200a;&#x0003d;&#x0200a;23)</td><td align="left" rowspan="1" colspan="1">Control, unknown relationship (n&#x0200a;&#x0003d;&#x0200a;66)</td><td align="left" rowspan="1" colspan="1">Controls (n&#x0200a;&#x0003d;&#x0200a;79)</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">c.-28C&#x0003e;T</td><td align="left" rowspan="1" colspan="1">CC</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">CT</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">TT</td><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">7</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">c.47T&#x0003e;C</td><td align="left" rowspan="1" colspan="1">TT</td><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">(p.V16A)</td><td align="left" rowspan="1" colspan="1">TC</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">7</td><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">CC</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">c.83C&#x0003e;T</td><td align="left" rowspan="1" colspan="1">CC</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">(p.A28V)</td><td align="left" rowspan="1" colspan="1">CT</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">TT</td><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">7</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">c.471G&#x0003e;A</td><td align="left" rowspan="1" colspan="1">GG</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">GA</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">AA</td><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">7</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">c.621G&#x0003e;A</td><td align="left" rowspan="1" colspan="1">GG</td><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1">19</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">GA</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">AA</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">c.622&#x0002b;8T&#x0003e;C</td><td align="left" rowspan="1" colspan="1">TT</td><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1">19</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">TC</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">CC</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">c.721&#x0002b;52G&#x0003e;A</td><td align="left" rowspan="1" colspan="1">GG</td><td align="left" rowspan="1" colspan="1">10<xref ref-type="table-fn" rid="nt103">a</xref></td><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">GA</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">AA</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">c.885A&#x0003e;G</td><td align="left" rowspan="1" colspan="1">AA</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">AG</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">GG</td><td align="left" rowspan="1" colspan="1">10<xref ref-type="table-fn" rid="nt103">a</xref></td><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">c.954&#x0002b;28T&#x0003e;C</td><td align="left" rowspan="1" colspan="1">TT</td><td align="left" rowspan="1" colspan="1">10<xref ref-type="table-fn" rid="nt103">a</xref></td><td align="left" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1">19</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">TC</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">CC</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>c.977T&#x0003e;C</bold></td><td align="left" rowspan="1" colspan="1"><bold>TT</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><bold>6</bold></td><td align="left" rowspan="1" colspan="1"><bold>54</bold></td><td align="left" rowspan="1" colspan="1"><bold>79</bold></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>(p.L326P)</bold></td><td align="left" rowspan="1" colspan="1"><bold>TC</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><bold>13</bold></td><td align="left" rowspan="1" colspan="1"><bold>17</bold></td><td align="left" rowspan="1" colspan="1"><bold>12</bold></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><bold>CC</bold></td><td align="left" rowspan="1" colspan="1"><bold>11</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">c.1059C&#x0003e;T</td><td align="left" rowspan="1" colspan="1">CC</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">CT</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">TT</td><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">7</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">c.1107C&#x0003e;T</td><td align="left" rowspan="1" colspan="1">CC</td><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1">19</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">CT</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">TT</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt103"><label>a</label><p>Low DNA quality prevented the determination of the genotypes in one amplicon from a single affected dog.</p></fn></table-wrap-foot></table-wrap></sec></sec><sec id="s3"><title>Discussion</title><p>We have applied an efficient SNP-based homozygosity mapping strategy to map the causative gene for OI in Dachshunds using only five affected dogs and five obligate carriers. The special population structure of purebred dog breeds with a limited amount of inbreeding on the one hand increases the occurrence of recessive phenotypes and on the other hand provides ideal prerequisites to map the underlying genes for these traits <xref ref-type="bibr" rid="pgen.1000579-Karlsson1">&#x0005b;16&#x0005d;</xref>. In this study we did not have enough high-quality DNA samples of unrelated Dachshunds for a genome-wide association study. However, the homozygosity mapping approach for this recessive trait basically required only samples from the five affected dogs to map the causative gene to one unique chromosome segment of 5.82 Mb. Adding the five obligate carriers further reduced this interval to 4.74 Mb. Thus the use of genome-wide canine SNP genotyping data enables very efficient positional cloning projects of Mendelian traits even if only very few samples are available.</p><p>The mapped OI interval contains a very good functional candidate gene, <italic>SERPINH1</italic>. We found a non-synonymous mutation in this gene, which is perfectly associated with the OI phenotype in Dachshunds, and confirmed the presence of this mutation on the genomic DNA and mRNA level. Although we cannot provide functional proof of the causality of the mutation at this time, the wealth of functional data, which are available for the <italic>SERPINH1</italic> gene, strongly supports the hypothesis that p.L326P is indeed the causative mutation. SERPINH1 or HSP47 is a molecular chaperone of the serpin family. It promotes the correct folding of the collagen I triple helix <xref ref-type="bibr" rid="pgen.1000579-Makareeva1">&#x0005b;17&#x0005d;</xref>. This triple-helical structure would normally not be stable at temperatures above 35 &#x000b0;C. SERPINH1 is present in high concentration in the endoplasmic reticulum and specifically binds to and stabilizes the triple helices of nascent collagens <xref ref-type="bibr" rid="pgen.1000579-Koide1">&#x0005b;18&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pgen.1000579-Thomson1">&#x0005b;20&#x0005d;</xref>. Apparently the complete absence of SERPINH1 leads to embryonic lethality due to deficiencies in several types of collagen <xref ref-type="bibr" rid="pgen.1000579-Nagai1">&#x0005b;14&#x0005d;</xref>. It is an evolutionary conserved protein with 97&#x00025; identity between human and dog and 64&#x00025; identity between human and zebrafish. The p.L326P mutation lies within the conserved serpin domain and the wildtype leucine is conserved across all SERPINH1 sequences while in other, more distantly related serpins like antitrypsin or ovalbumin, it is conservatively replaced by isoleucine, valine or methionine. It is located at the interface of helices hB, hC and hI (<xref ref-type="fig" rid="pgen-1000579-g005">Figure 5A</xref>) <xref ref-type="bibr" rid="pgen.1000579-Huber1">&#x0005b;21&#x0005d;</xref>. Leu326 has backbone dihedral angles &#x003a6;/&#x003a8; of about &#x02212;90/&#x0002b;88 degrees. Proline has a &#x003a6;-angle restricted to about &#x02212;60 degrees due to its five-membered ring and most frequently &#x003a8;-angles of &#x02212;45 or &#x0002b;135 degrees. Therefore, it is likely that the mutation L326P results in an increased strain. Furthermore, in the wildtype Leu326 donates a main-chain H-bond to Leu321 that is not possible with the imino acid proline (<xref ref-type="fig" rid="pgen-1000579-g005">Figure 5B</xref>). Thus it is conceivable that this mutation affects the proper folding and stability of the native conformation, possibly reducing the protein level significantly. Additionally, this non-conservative amino acid substitution could affect the ability of SERPINH1 to bind and stabilize collagen triple helices. We speculate that the p.L326P mutation in OI affected dogs probably does not represent a complete null allele but has some residual activity, which results in live-born dogs with a severe form of OI instead of the embryonic lethality seen in <italic>Serpinh1</italic> knock-out mice. The phenotype of OI affected dogs primarily indicates a deficiency in collagen I, the most abundant collagen, whereas basal membranes, which contain collagen IV, do not seem to be severely altered <xref ref-type="bibr" rid="pgen.1000579-Seeliger1">&#x0005b;13&#x0005d;</xref>.</p><p>Our finding of a <italic>SERPINH1</italic> p.L326P mutation in dogs with OI provides a valuable model for human medicine and identifies <italic>SERPINH1</italic> as a fifth OI gene in addition to <italic>COL1A1</italic>, <italic>COL1A2</italic>, <italic>CRTAP</italic>, and <italic>LEPRE1</italic>. It has already been shown that a functional SNP in the promoter of the human <italic>SERPINH1</italic> gene is associated in African American women with an increased risk for preterm premature rupture of membranes <xref ref-type="bibr" rid="pgen.1000579-Wang1">&#x0005b;22&#x0005d;</xref>. Our study indicates that coding mutations of the <italic>SERPINH1</italic> gene might be responsible for recessive forms of human OI, where no mutation in the four known OI genes has been found. It has been proposed to develop SERPINH1 binding molecules as drugs against fibrosis <xref ref-type="bibr" rid="pgen.1000579-Thomson2">&#x0005b;23&#x0005d;</xref>. The findings of our study emphasize that such a therapeutic strategy will have to be very carefully adjusted in order not to have adverse effects on the physiological production of collagen.</p><p>In conclusion, we have identified the p.L326P mutation in the canine <italic>SERPINH1</italic> gene as the candidate causative mutation for OI in Dachshunds. This result allows genetic testing and eradication of a lethal disease from the Dachshund breeding population. Our study also provides a defined animal model and a novel genetic mechanism for a lethal or severely debilitating human hereditary disease.</p></sec><sec sec-type="materials|methods" id="s4"><title>Materials and Methods</title><sec id="s4a"><title>Animals</title><p>We collected samples from OI affected rough-coated Dachshunds (n&#x0200a;&#x0003d;&#x0200a;11), their healthy littermates (n&#x0200a;&#x0003d;&#x0200a;22), sires (n&#x0200a;&#x0003d;&#x0200a;4), dams (n&#x0200a;&#x0003d;&#x0200a;7), and one grandmother. We performed parentage verification to confirm the pedigree documentation from the breeders (<xref ref-type="supplementary-material" rid="pgen.1000579.s001">Figure S1</xref>). In addition, we collected two Dachshunds recorded as sires of OI affected puppies. Parents of affected offspring were classified as obligate carriers (n&#x0200a;&#x0003d;&#x0200a;13). We also collected 66 unrelated healthy Dachshunds resulting in a total of 113 samples from the Dachshund breed. Furthermore, we sampled 79 control dogs from 75 different breeds for the re-sequencing of <italic>SERPINH1</italic> exon 5 (<xref ref-type="supplementary-material" rid="pgen.1000579.s004">Table S3</xref>).</p></sec><sec id="s4b"><title>DNA and RNA extraction</title><p>Genomic DNA was isolated from blood or tissue using the Nucleon Bacc2 kit (GE Healthcare). Total RNA was isolated from bone or skin using Trizol reagent according to the manufacturer's instructions (Invitrogen).</p></sec><sec id="s4c"><title>Linkage analysis in candidate genes</title><p>Microsatellite markers were amplified using the Multiplex PCR Kit (Qiagen) and fragment size analyses were determined on an ABI 3730 capillary sequencer (Applied Biosystems) and analyzed with the GeneMapper 4.0 software (Applied Biosystems). Twopoint parametric linkage analysis under the assumption of OI segregating as a biallelic autosomal recessive trait with complete penetrance was performed with Merlin software version 1.1.2 <xref ref-type="bibr" rid="pgen.1000579-Abecasis1">&#x0005b;24&#x0005d;</xref>. The frequency of the mutant allele in the considered population was unknown and there were no data available that would have made it possible to estimate the frequency in a reliable manner. For the calculations a frequency of 0.001 for the mutant allele was assumed. The LOD score test statistic was used to estimate the proportion of linked families and the corresponding maximum heterogeneity LOD score. Within the available families, a maximum LOD score of 5.573 would have been possible. To reconstruct the most likely haplotypes, we applied the &#x02018;best&#x02019; option of the Merlin software.</p></sec><sec id="s4d"><title>Mapping of the OI mutation</title><p>Genomic DNA from five affected Dachshunds and five carriers was genotyped on the canine Affymetrix version 2 SNP genotyping microarray (49,663 SNPs). The results were analyzed with PLINK &#x0005b;<ext-link ext-link-type="uri" xlink:href="http://pngu.mgh.harvard.edu/~purcell/plink/">http://pngu.mgh.harvard.edu/~purcell/plink/</ext-link>&#x0005d;. To identify extended homozygous regions with allele sharing across all five affected animals the options &#x02013;homozyg-group and &#x02013;homozyg-match were applied. All given positions correspond to the build 2.1 dog genome assembly &#x0005b;<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/mapview/map_search.cgi?taxid=9615">http://www.ncbi.nlm.nih.gov/projects/mapview/map_search.cgi?taxid=9615</ext-link>&#x0005d;.</p></sec><sec id="s4e"><title>Mutation analysis</title><p>Primers for the amplification of each of the four <italic>SERPINH1</italic> coding exons with flanking regions were designed with the software Primer3 &#x0005b;<ext-link ext-link-type="uri" xlink:href="http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi">http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi</ext-link>&#x0005d; after masking repetitive sequences with RepeatMasker (Smit, A.F.A and Green, P. &#x0005b;<ext-link ext-link-type="uri" xlink:href="http://repeatmasker.genome.washington.edu/">http://repeatmasker.genome.washington.edu/</ext-link>&#x0005d;). The sequences of the primers are listed in <xref ref-type="supplementary-material" rid="pgen.1000579.s005">Table S4</xref>. For the mutation analysis PCR products were amplified of two affected and two unrelated healthy dogs using TopTaq polymerase (Qiagen). The subsequent re-sequencing of the PCR products was performed after rAPid alkaline phosphatase (Roche) and exonuclease I (New England Biolabs) treatment using both PCR primers with the ABI BigDye Terminator Sequencing Kit 3.1 (Applied Biosystems) on an ABI 3730. Sequence data were analyzed with Sequencher 4.8 (GeneCodes).</p></sec><sec id="s4f"><title>RT&#x02013;PCR</title><p>Aliquots of 1 &#x000b5;g total RNA were reverse transcribed into cDNA using 20 pmol (T)<sub>24</sub>V primer and Omniscript reverse transcriptase (Qiagen). Two microliters of the cDNA were used as a template in PCR. PCR reactions were performed as described above and primer sequences are given in <xref ref-type="supplementary-material" rid="pgen.1000579.s006">Table S5</xref>. The canine <italic>SERPINH1</italic> cDNA sequence was deposited under accession FN395288 in the EMBL nucleotide database.</p></sec><sec id="s4g"><title>Homology modeling</title><p>Models of wildtype and mutant SERPINH1were produced employing 3D-JIGSAW <xref ref-type="bibr" rid="pgen.1000579-Bates1">&#x0005b;25&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000579-Bates2">&#x0005b;26&#x0005d;</xref> with template PDB entries1OO8 and 1OPH <xref ref-type="bibr" rid="pgen.1000579-Dementiev1">&#x0005b;27&#x0005d;</xref>. Figures were prepared using PyMOL &#x0005b;<ext-link ext-link-type="uri" xlink:href="http://www.pymol.org">http://www.pymol.org</ext-link>&#x0005d;.</p></sec></sec><sec sec-type="supplementary-material" id="s5"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pgen.1000579.s001"><label>Figure S1</label><caption><p>Pedigrees of sampled Dachshunds. Animals genotyped on the SNP chip are indicated by asterisks. The genotypes for the <italic>SERPINH1</italic> c.977T&#x0003e;C mutation are given below the symbols.</p><p>(0.02 MB PDF)</p></caption><media xlink:href="pgen.1000579.s001.pdf" mimetype="application" mime-subtype="pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1000579.s002"><label>Table S1</label><caption><p>Microsatellites.</p><p>(0.02 MB XLS)</p></caption><media xlink:href="pgen.1000579.s002.xls" mimetype="application" mime-subtype="vnd.ms-excel"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1000579.s003"><label>Table S2</label><caption><p>Results of homozygosity mapping.</p><p>(0.04 MB XLS)</p></caption><media xlink:href="pgen.1000579.s003.xls" mimetype="application" mime-subtype="vnd.ms-excel"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1000579.s004"><label>Table S3</label><caption><p>List of dog breeds tested for <italic>SERPINH1</italic> exon 5 SNPs.</p><p>(0.02 MB XLS)</p></caption><media xlink:href="pgen.1000579.s004.xls" mimetype="application" mime-subtype="vnd.ms-excel"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1000579.s005"><label>Table S4</label><caption><p>Primer sequences for the amplification of canine <italic>SERPINH1</italic> coding exons.</p><p>(0.02 MB XLS)</p></caption><media xlink:href="pgen.1000579.s005.xls" mimetype="application" mime-subtype="vnd.ms-excel"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1000579.s006"><label>Table S5</label><caption><p>Primer sequences for the amplification of canine <italic>SERPINH1</italic> cDNA.</p><p>(0.03 MB XLS)</p></caption><media xlink:href="pgen.1000579.s006.xls" mimetype="application" mime-subtype="vnd.ms-excel"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1000579.s007"><label>Video S1</label><caption><p>Affected Dachshund puppy showing wobbly gait due to ligament hyperlaxity and unstable joints, especially the carpal joints.</p><p>(6.96 MB AVI)</p></caption><media xlink:href="pgen.1000579.s007.avi" mimetype="video" mime-subtype="x-msvideo"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>The authors would like to thank Brigitta Colomb and Tara Biagi for expert technical assistance. The authors would also like to thank all dog owners for donating samples and sharing pedigree data of their dogs.</p></ack><ref-list><title>References</title><ref id="pgen.1000579-Rau1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rau</surname><given-names>F</given-names></name><name><surname>Glorieux</surname><given-names>F</given-names></name></person-group><year>2004</year><article-title>Osteogenesis imperfecta.</article-title><source>Lancet</source><volume>363</volume><fpage>1377</fpage><lpage>1385</lpage><pub-id pub-id-type="pmid">15110498</pub-id></mixed-citation></ref><ref id="pgen.1000579-Marini1"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marini</surname><given-names>JC</given-names></name><name><surname>Forlino</surname><given-names>A</given-names></name><name><surname>Cabral</surname><given-names>WA</given-names></name><name><surname>Barnes</surname><given-names>AM</given-names></name><name><surname>San Antonio</surname><given-names>JD</given-names></name><etal/></person-group><year>2007</year><article-title>Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans.</article-title><source>Hum Mutat</source><volume>28</volume><fpage>209</fpage><lpage>221</lpage><pub-id pub-id-type="pmid">17078022</pub-id></mixed-citation></ref><ref id="pgen.1000579-Cabral1"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cabral</surname><given-names>WA</given-names></name><name><surname>Chang</surname><given-names>W</given-names></name><name><surname>Barnes</surname><given-names>AM</given-names></name><name><surname>Weis</surname><given-names>M</given-names></name><name><surname>Scott</surname><given-names>MA</given-names></name><etal/></person-group><year>2007</year><article-title>Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal/severe osteogenesis imperfecta.</article-title><source>Nat Genet</source><volume>39</volume><fpage>359</fpage><lpage>365</lpage><pub-id pub-id-type="pmid">17277775</pub-id></mixed-citation></ref><ref id="pgen.1000579-Morello1"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morello</surname><given-names>R</given-names></name><name><surname>Bertin</surname><given-names>TK</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Hicks</surname><given-names>J</given-names></name><name><surname>Tonachini</surname><given-names>L</given-names></name><etal/></person-group><year>2006</year><article-title>CRTAP is required for prolyl 3- hydroxylation and mutations cause recessive osteogenesis imperfecta.</article-title><source>Cell</source><volume>127</volume><fpage>291</fpage><lpage>304</lpage><pub-id pub-id-type="pmid">17055431</pub-id></mixed-citation></ref><ref id="pgen.1000579-Barnes1"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barnes</surname><given-names>AM</given-names></name><name><surname>Chang</surname><given-names>W</given-names></name><name><surname>Morello</surname><given-names>R</given-names></name><name><surname>Cabral</surname><given-names>WA</given-names></name><name><surname>Weis</surname><given-names>M</given-names></name><etal/></person-group><year>2006</year><article-title>Deficiency of cartilage-associated protein in recessive lethal osteogenesis imperfecta.</article-title><source>N Engl J Med</source><volume>355</volume><fpage>2757</fpage><lpage>2764</lpage><pub-id pub-id-type="pmid">17192541</pub-id></mixed-citation></ref><ref id="pgen.1000579-Baldridge1"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baldridge</surname><given-names>D</given-names></name><name><surname>Schwarze</surname><given-names>U</given-names></name><name><surname>Morello</surname><given-names>R</given-names></name><name><surname>Lennington</surname><given-names>J</given-names></name><name><surname>Bertin</surname><given-names>TK</given-names></name><etal/></person-group><year>2008</year><article-title><italic>CRTAP</italic> and <italic>LEPRE1</italic> mutations in recessive osteogenesis imperfecta.</article-title><source>Hum Mutat</source><volume>29</volume><fpage>1435</fpage><lpage>1442</lpage><pub-id pub-id-type="pmid">18566967</pub-id></mixed-citation></ref><ref id="pgen.1000579-Bodian1"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bodian</surname><given-names>DL</given-names></name><name><surname>Chan</surname><given-names>TF</given-names></name><name><surname>Poon</surname><given-names>A</given-names></name><name><surname>Schwarze</surname><given-names>U</given-names></name><name><surname>Yang</surname><given-names>K</given-names></name><etal/></person-group><year>2009</year><article-title>Mutation and polymorphism spectrum in osteogenesis imperfecta type II: implications for genotype-phenotype relationships.</article-title><source>Hum Mol Genet</source><volume>18</volume><fpage>463</fpage><lpage>471</lpage><pub-id pub-id-type="pmid">18996919</pub-id></mixed-citation></ref><ref id="pgen.1000579-Campbell1"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campbell</surname><given-names>BG</given-names></name><name><surname>Wootton</surname><given-names>JA</given-names></name><name><surname>MacLeod</surname><given-names>JN</given-names></name><name><surname>Minor</surname><given-names>RR</given-names></name></person-group><year>2000</year><article-title>Sequence of normal canine <italic>COL1A1</italic> cDNA and identification of a heterozygous alpha1(I) collagen Gly208Ala mutation in a severe case of canine osteogenesis imperfecta.</article-title><source>Arch Biochem Biophys</source><volume>384</volume><fpage>37</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">11147834</pub-id></mixed-citation></ref><ref id="pgen.1000579-Campbell2"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campbell</surname><given-names>BG</given-names></name><name><surname>Wootton</surname><given-names>JA</given-names></name><name><surname>Macleod</surname><given-names>JN</given-names></name><name><surname>Minor</surname><given-names>RR</given-names></name></person-group><year>2001</year><article-title>Canine <italic>COL1A2</italic> mutation resulting in C-terminal truncation of pro-alpha2(I) and severe osteogenesis imperfecta.</article-title><source>J Bone Miner Res</source><volume>16</volume><fpage>1147</fpage><lpage>1153</lpage><pub-id pub-id-type="pmid">11393792</pub-id></mixed-citation></ref><ref id="pgen.1000579-Holmes1"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holmes</surname><given-names>JR</given-names></name><name><surname>Price</surname><given-names>CHG</given-names></name></person-group><year>1957</year><article-title>Multiple fractures in a collie: Osteogenesis imperfecta.</article-title><source>Vet Rec</source><volume>69</volume><fpage>1047</fpage><lpage>1050</lpage></mixed-citation></ref><ref id="pgen.1000579-Lettow1"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lettow</surname><given-names>E</given-names></name><name><surname>Dammrich</surname><given-names>K</given-names></name></person-group><year>1960</year><article-title>Clinic and pathology of osteogenesis imperfecta in young dogs.</article-title><source>Zbl Vet Med</source><volume>7</volume><fpage>936</fpage><lpage>966</lpage></mixed-citation></ref><ref id="pgen.1000579-Schmidt1"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>V</given-names></name></person-group><year>1967</year><article-title>Osteogenesis imperfecta in 2 collie litter siblings.</article-title><source>Wien Tier&#x000e4;rztl Monatsschr</source><volume>54</volume><fpage>92</fpage><lpage>100</lpage></mixed-citation></ref><ref id="pgen.1000579-Seeliger1"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seeliger</surname><given-names>F</given-names></name><name><surname>Leeb</surname><given-names>T</given-names></name><name><surname>Peters</surname><given-names>M</given-names></name><name><surname>Brugmann</surname><given-names>M</given-names></name><name><surname>Fehr</surname><given-names>M</given-names></name><etal/></person-group><year>2003</year><article-title>Osteogenesis imperfecta in two litters of dachshunds.</article-title><source>Vet Pathol</source><volume>40</volume><fpage>530</fpage><lpage>539</lpage><pub-id pub-id-type="pmid">12949410</pub-id></mixed-citation></ref><ref id="pgen.1000579-Nagai1"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagai</surname><given-names>N</given-names></name><name><surname>Hosokawa</surname><given-names>M</given-names></name><name><surname>Itohara</surname><given-names>S</given-names></name><name><surname>Adachi</surname><given-names>E</given-names></name><name><surname>Matsushita</surname><given-names>T</given-names></name><etal/></person-group><year>2000</year><article-title>Embryonic lethality of molecular chaperone hsp47 knockout mice is associated with defects in collagen biosynthesis.</article-title><source>J Cell Biol</source><volume>150</volume><fpage>1499</fpage><lpage>1506</lpage><pub-id pub-id-type="pmid">10995453</pub-id></mixed-citation></ref><ref id="pgen.1000579-Ishida1"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishida</surname><given-names>Y</given-names></name><name><surname>Kubota</surname><given-names>H</given-names></name><name><surname>Yamamoto</surname><given-names>A</given-names></name><name><surname>Kitamura</surname><given-names>A</given-names></name><name><surname>B&#x000e4;chinger</surname><given-names>HP</given-names></name><etal/></person-group><year>2006</year><article-title>Type I collagen in Hsp47-null cells is aggregated in endoplasmic reticulum and deficient in N-propeptide processing and fibrillogenesis.</article-title><source>Mol Biol Cell</source><volume>17</volume><fpage>2346</fpage><lpage>2355</lpage><pub-id pub-id-type="pmid">16525016</pub-id></mixed-citation></ref><ref id="pgen.1000579-Karlsson1"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karlsson</surname><given-names>EK</given-names></name><name><surname>Lindblad-Toh</surname><given-names>K</given-names></name></person-group><year>2008</year><article-title>Leader of the pack: gene mapping in dogs and other model organisms.</article-title><source>Nat Rev Genet</source><volume>9</volume><fpage>713</fpage><lpage>725</lpage><pub-id pub-id-type="pmid">18714291</pub-id></mixed-citation></ref><ref id="pgen.1000579-Makareeva1"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Makareeva</surname><given-names>E</given-names></name><name><surname>Leikin</surname><given-names>S</given-names></name></person-group><year>2007</year><article-title>Procollagen triple helix assembly: an unconventional chaperone-assisted folding paradigm.</article-title><source>PLoS ONE</source><volume>2</volume><fpage>e1029</fpage><comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0001029">10.1371/journal.pone.0001029</ext-link></comment><pub-id pub-id-type="pmid">17925877</pub-id></mixed-citation></ref><ref id="pgen.1000579-Koide1"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koide</surname><given-names>T</given-names></name><name><surname>Asada</surname><given-names>S</given-names></name><name><surname>Takahara</surname><given-names>Y</given-names></name><name><surname>Nishikawa</surname><given-names>Y</given-names></name><name><surname>Nagata</surname><given-names>K</given-names></name><etal/></person-group><year>2006</year><article-title>Specific recognition of the collagen triple helix by chaperone HSP47: minimal structural requirement and spatial molecular orientation.</article-title><source>J Biol Chem</source><volume>281</volume><fpage>3432</fpage><lpage>3438</lpage><pub-id pub-id-type="pmid">16326708</pub-id></mixed-citation></ref><ref id="pgen.1000579-Koide2"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koide</surname><given-names>T</given-names></name><name><surname>Nishikawa</surname><given-names>Y</given-names></name><name><surname>Asada</surname><given-names>S</given-names></name><name><surname>Yamazaki</surname><given-names>CM</given-names></name><name><surname>Takahara</surname><given-names>Y</given-names></name><etal/></person-group><year>2006</year><article-title>Specific recognition of the collagen triple helix by chaperone HSP47. II. The HSP47-binding structural motif in collagens and related proteins.</article-title><source>J Biol Chem</source><volume>281</volume><fpage>11177</fpage><lpage>11185</lpage><pub-id pub-id-type="pmid">16484215</pub-id></mixed-citation></ref><ref id="pgen.1000579-Thomson1"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomson</surname><given-names>CA</given-names></name><name><surname>Tenni</surname><given-names>R</given-names></name><name><surname>Ananthanarayanan</surname><given-names>VS</given-names></name></person-group><year>2003</year><article-title>Mapping Hsp47 binding site(s) using CNBr peptides derived from type I and type II collagen.</article-title><source>Protein Sci</source><volume>12</volume><fpage>1792</fpage><lpage>1800</lpage><pub-id pub-id-type="pmid">12876328</pub-id></mixed-citation></ref><ref id="pgen.1000579-Huber1"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huber</surname><given-names>R</given-names></name><name><surname>Carrell</surname><given-names>RW</given-names></name></person-group><year>1989</year><article-title>Implications of the three-dimensional structure of alpha 1-antitrypsin for structure and function of serpins.</article-title><source>Biochemistry</source><volume>28</volume><fpage>8951</fpage><lpage>8966</lpage><pub-id pub-id-type="pmid">2690952</pub-id></mixed-citation></ref><ref id="pgen.1000579-Wang1"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Parry</surname><given-names>S</given-names></name><name><surname>Macones</surname><given-names>G</given-names></name><name><surname>Sammel</surname><given-names>MD</given-names></name><name><surname>Kuivaniemi</surname><given-names>H</given-names></name><etal/></person-group><year>2006</year><article-title>A functional SNP in the promoter of the <italic>SERPINH1</italic> gene increases risk of preterm premature rupture of membranes in African Americans.</article-title><source>Proc Natl Acad Sci USA</source><volume>103</volume><fpage>13463</fpage><lpage>13467</lpage><pub-id pub-id-type="pmid">16938879</pub-id></mixed-citation></ref><ref id="pgen.1000579-Thomson2"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomson</surname><given-names>CA</given-names></name><name><surname>Atkinson</surname><given-names>HM</given-names></name><name><surname>Ananthanarayanan</surname><given-names>VS</given-names></name></person-group><year>2005</year><article-title>Identification of small molecule chemical inhibitors of the collagen-specific chaperone Hsp47.</article-title><source>J Med Chem</source><volume>48</volume><fpage>1680</fpage><lpage>1684</lpage><pub-id pub-id-type="pmid">15743211</pub-id></mixed-citation></ref><ref id="pgen.1000579-Abecasis1"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abecasis</surname><given-names>GR</given-names></name><name><surname>Cherny</surname><given-names>SS</given-names></name><name><surname>Cookson</surname><given-names>WO</given-names></name><name><surname>Cardon</surname><given-names>LR</given-names></name></person-group><year>2002</year><article-title>Merlin - rapid analysis of dense genetic maps using sparse gene flow trees.</article-title><source>Nature Genet</source><volume>30</volume><fpage>97</fpage><lpage>101</lpage><pub-id pub-id-type="pmid">11731797</pub-id></mixed-citation></ref><ref id="pgen.1000579-Bates1"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bates</surname><given-names>PA</given-names></name><name><surname>Kelley</surname><given-names>LA</given-names></name><name><surname>MacCallum</surname><given-names>RM</given-names></name><name><surname>Sternberg</surname><given-names>MJ</given-names></name></person-group><year>2001</year><article-title>Enhancement of protein modeling by human intervention in applying the automatic programs 3D-JIGSAW and 3D-PSSM.</article-title><source>Proteins, Suppl</source><volume>5</volume><fpage>39</fpage><lpage>46</lpage></mixed-citation></ref><ref id="pgen.1000579-Bates2"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bates</surname><given-names>PA</given-names></name></person-group><year>2002</year><article-title>Domain Fishing: a first step in protein comparative modelling.</article-title><source>Bioinformatics</source><volume>18</volume><fpage>1141</fpage><lpage>1142</lpage><pub-id pub-id-type="pmid">12176841</pub-id></mixed-citation></ref><ref id="pgen.1000579-Dementiev1"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dementiev</surname><given-names>A</given-names></name><name><surname>Simonovic</surname><given-names>M</given-names></name><name><surname>Volz</surname><given-names>K</given-names></name><name><surname>Gettins</surname><given-names>PG</given-names></name></person-group><year>2003</year><article-title>Canonical inhibitor-like interactions explain reactivity of alpha1-proteinase inhibitor Pittsburgh and antithrombin with proteinases.</article-title><source>J Biol Chem</source><volume>278</volume><fpage>37881</fpage><lpage>37887</lpage><pub-id pub-id-type="pmid">12860985</pub-id></mixed-citation></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors have declared that no competing interests exist.</p></fn><fn fn-type="financial-disclosure"><p>This study was financed in part by grant no. 85 from the Albert-Heim-Foundation and by grant no. 07/09 of the UniBern Research Foundation to TL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></fn></fn-group></back></article>